Papanicolaou test


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to Papanicolaou test: Papanicolaou stain

Pa·pa·ni·co·laou test

 (pä′pə-nē′kə-lou′, păp′ə-nĭk′ə-lou′)
n.
The Pap smear.

Papanicolaou test

(ˌpæpəˈnɪkəluː) or

Papanicolaou smear

n
(Medicine) the full name for Pap test

Pap′

(or pap′) test`

(pæp)
n.
1. a test for cancer of the cervix, consisting of the staining of cells taken in a cervical or vaginal smear (Pap′(or pap′) smear`) for examination of exfoliated cells.
2. a vaginal Pap smear used to evaluate estrogen levels.
3. an examination of exfoliated cells in any body fluid for cancer cells.
Also called Papanicolaou test.
[1960–65; after George Papanicolaou (1883–1962), U.S. cytologist, born in Greece, who developed the staining method]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Papanicolaou test - a method of examining stained cells in a cervical smear for early diagnosis of uterine cancer
cervical smear, Pap smear, Papanicolaou smear - a sample of secretions and superficial cells of the uterine cervix and uterus; examined with a microscope to detect any abnormal cells
diagnostic assay, diagnostic test - an assay conducted for diagnostic purposes
References in periodicals archive ?
The guidelines recommend that all females ages 25 to 65 undergo a papanicolaou test (also known as pap smear test) every three to five years, and all females aged 15 to 26 years receive an HPV vaccine.
Future research should focus on overcoming the underlying factors that contribute to this mortality gap (differential follow-up for abnormal Papanicolaou test results and barriers to care after diagnosis) and on determining why black women and older women receive different and inadequate treatment for the same disease," wrote Dr.
Currently, 4 HPV testing platforms are approved by the FDA for triage of a Papanicolaou test diagnosis of atypical squamous cells of undetermined significance (reflex testing) and as an adjunct to the Papanicolaou test (cotesting) in women 30 years and older: HC2 was approved for these purposes in 2003, Cervista in 2009, and Aptima and cobas in 2011 (cobas was further approved for primary HPV screening of women 25 years and older in 2014).
It is according that annually 132,000 new cases were diagnosed and 74,000 deaths in Bharat, that is almost third of the worldwide cancer deaths [5] Screening of cervical cancer will be done by Papanicolaou test that is believed to be the gold commonplace forever.
The Papanicolaou test, also called pap test or pap smear, can prevent up to 80 per cent of cervical cancers, and organised routine checks have reduced cervical cancer mortality considerably worldwide.
Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.
Accuracy of Papanicolaou test in screening for and follow up of cervical cytological abnormalities: a systemic review.
Liquid-based Papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomas.
Knowledge about prevention of cervical cancer, locus of control and Papanicolaou test screening
million of unsecured women passed the Papanicolaou Test.